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ABSTRACT
MASS SPECTROMETRY: AN IDEAL METHOD FOR RNA MODIFICATION
ANALYSIS
Samuel Wein
Benjamin A. Garcia
Currently there is no good way to measure and find the exact location of multiple RNA
modifications. Existing technology can effectively find single varieties of modifications, but
cannot identify co-occurrence. As the field of proteomics has shown, mass spectrometry is
a powerful and versatile technique assessing broad ranges of chemical modifications in the
context of the cellular environment. In this project I used our expertise in proteomics to
build a mass spectrometry based platform for identifying RNA modifications. I have since
set up both software and analytical platforms querying RNA modifications, and used this
platform to survey human tRNA samples and identify what modifications there are, and
where they occur.
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PREFACE
The process of research leading to this dissertation was not nearly as linear as it is presented
in this work. There were lots of false starts, bits of tribal knowledge to be learned and a
good deal of work that could be the subject of numerous other dissertations had I infinite
time to pursue it. I hope that this work is helpful to any scholars who come after me, and
I welcome any questions or requests for further insight into this research. This has been a
labor of love and creativity and I am immensely grateful to have been given the opportunity
to undertake it.
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CHAPTER 1 : Background
1.1. Introduction
The wild world of RNA The study of RNA has been of interest to biologists for
some time now. RNA fills many different roles in the cell; it is the intermediary between
DNA and protein in the form of mRNA, it is the effector for translation in the form of
tRNA, it constitutes a key component of the ribosome in the form of rRNA, and it is
a regulatory molecule controlling translation levels in the form of miRNA. For almost as
long as we have known that the sequence of RNA molecules (the nucleic acid sequence)
affects its function, we have known that there are also other chemical modifications which
shape the functionality of the molecule. Since these modifications mostly happen after the
transcription from DNA to RNA, I will refer to them as post-transcriptional modifications
(PTMs) throughout this work. It should be noted that there are also modifications that can
occur to mRNA during translation (that is co-translationally)Afonin et al. (2012) for the
purposes of this work I lump them in with PTMs. In this chapter I will explore broadly the
existing understanding of RNA biology, and the effects of modifications on the RNA. I will
then look at mass spectrometry (MS) as an analytical technique, its history, and how it can
be used to solve critical problems that currently exist in the field of research surrounding
modifications to RNA. To describe this discipline I use the term epitranscriptomics. I
will also lead the reader through a close look at the field of proteomics, a much more
well-developed field encompassing the study of proteins and their modifications by mass
spectrometry.
What your traditional RNA sequencing techniques won’t tell you The field of
RNA sequencing is already relatively heavily populated. Scientists are able to sequence large
swathes of RNA quickly and inexpensively with reverse transcription polymerase chain re-
action (rtPCR) followed by “next-generation” DNA sequencing (see figure 1 for details)
Bustin et al. (2005). Modifications which do not add or remove bases to the RNA molecule
1
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Figure 1: Reverse transcription polymerase chain reaction consists of two distinct steps,
the initial reverse transcription followed by the amplification of reverse transcribed product
through the polymerase chain reaction (PCR). In the reverse transcription step the enzyme
reverse transcriptase creates a DNA copy of any RNA matching a short DNA-primer. This
product is called cDNA. The cDNA is then amplified through successive rounds of PCR.
During the reverse transcription phase any post-transcriptional modifications to the RNA
are replaced in the cDNA by their canonical base paired nucleotide, making rtPCR incom-
patible with identifying RNA modifications. rtPCR is a prequisite to sequencing since all
extant sequencing methods require substantially more nucleic acid than is available directly
from biological sources. Wein (2019)
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are not preserved during traditional methods of nucleotide sequencing. During the PCR
amplification step prior to sequencing, modifications are not templated to new copies and
are instead transcribed as whichever base they pair to. As we have become increasingly
aware of the importance of these chemical modifications, it has become apparent that we
need better options for sequencing modified RNA. Currently several techniques exist to
detect single specific modifications. For example, bisulfite sequencing can be used to detect
5-methylcytosine Gilbert et al. (2016), and PSI-seq can detect pseudouridine Lovejoy et al.
(2014), however these techniques only work for a single modification each. Leaving it im-
possible to determine co-occurrences of modifications. In order to identify and characterize
these modifications, we have turned to the technique of mass spectrometry as it offers an
unbiased and sensitive approach to determining analyte composition. MS allows us to de-
tect the mass shift between unmodified and modified oligonucleotides and does not require
amplification in order to provide enough sample for sequencing. Furthermore, by fragment-
ing nucleic acids and capturing tandem mass spectra, it is possible to localize which base
is modified by comparing the mass shift of individual fragments. Other researchers have
shown that it is eminently possible to observe miRNAs by mass spectrometry Kullolli et al.
(2014), Yu et al. (2005) and other work on larger tRNA (Hossain and Limbach (2007)) and
rRNAs (Taoka et al. (2016a)) has demonstrated that mass spectrometry provides a good
mechanism for discovering and localizing modifications on these larger molecules Taoka
et al. (2015). My work here extends this search and, crucially, presents a new software
platform to make the analysis of complex modifications and complex mixtures tractable.
Both the analytical and bioinformatic methods for nucleotide mass spectrometry are less
well developed in comparison to those for protein mass spectrometry. Here, I show my
work to create methodology to perform nanoflow HPLC and tandem mass spectrometry on
undigested miRNA-like oligonucleotides (˜20-25 nucleotide bases in length) and on longer
RNA types (such as tRNA) when coupled with digestion by an enzyme, as well as adapt to
and develop software tools for their analysis. I have expanded upon work by other groups to
create an analytical method to separate and sequence RNAs, and have created new software
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to analyze the tandem MS results by building off of OpenMS, an open-source set of libraries
and programs developed to facilitate MS analysis Rost et al. (2016).
Mass spectrometry as an analytical technique Mass spectrometry is a technique
with a long history of use for a variety of fields Thomson (1921). In mass spectrometry,
molecules in the sample of interest are ionized (endowed with an electrical charge) and
their mass to charge ratio is measured. This technique is broadly applicable, being useful
for everything from metals (using ion coupled plasma mass spectrometry Balcaen et al.
(2015)) to proteins and other biopolymers (using electrospray ionization mass spectrometry
Fenn et al. (1989)). In this work I will discuss the history of mass spectrometry, which
has led us to this point, and how the technique can be expanded to the new field of RNA
modifications. Specifically I will look at lessons from the field of proteomics (the large-scale
study of proteins) which has a relatively mature software and analytical ecosystem, and
how we can extend those tools to RNA as another bio-polymer.
1.2. RNA
What is RNA? RNA, or RiboNucleic Acid, is a polymeric biomolecule composed of a
chain of nucleotides. Much like the more widely discussed DNA, each nucleotide consists
of a nitrogenous base, a 5-carbon sugar–Ribose, and a phosphate group. Crucially there
are different bases with different chemical compositions. For RNA, these are canonically,
Adenine (A), Guanine (G), Cytosine (C), and Uracil (U). These nucleotides form a linear
sequence, with the base of one attached to the phosphate of the next. The identity of
the base is important in a huge number of biological processes such as protein production,
regulation of enzyme levels, and degradation of invading viral particles. Nomenclature for
describing the different ”sides” of the RNA talks about 5’ and 3’ ends. These correspond
to which carbon on the ribose (numbered 1’ to 5’) is exposed. Unlike DNA, RNA is often
single stranded, and forms a much wider variety of secondary and tertiary structures. Com-
plementary bases (A pairs with U, C pairs with G) form hydrogen bonds between different
portions of the same molecule, enabling the formation of a diverse group of key structures
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Figure 2: Diagram showing the components of an RNA nucleotide. Note that the carbons
of the ribose are numbered 1’-5’ (pronounced one-prime to five-prime) Sahib (2014)
such as stem-loops Svoboda and Cara (2006), which form the basis of both tRNA function
and pre-miRNA recognition MacRae et al. (2007).
Messenger RNA Messenger RNAs (mRNA) act as an intermediary information carrier
between genes, which are stored in DNA, and proteins, which are the main effector molecules
in the cell. They are produced when the protein complex RNA polymerase transcribes the
sequence of a gene into primary transcript mRNA which is then spliced and processed
into mature mRNA. The sequence of bases in the mRNA prescribes the sequence of amino
acids in the protein for which it corresponds. The translation from messenger RNA to
proteins by the ribosome is dependent on specific recognition, by transfer RNA (tRNA), of
a complementary three-mer of bases on the messenger RNA (the codon).
In eukaryotes, mRNA maturation consists of the removal of intronic sequences by the
spliceosome complex. The remaining mRNA sections (called exons) are then joined to-
gether to form the final sequence. As well as splicing, eukaryotic mRNA undergoes the
addition of a 5’ terminal 7-methylguanosine called the 5’Cap. This nucleotide is linked to
the first residue of the sequence by an unusual 5’ to 5’ triphosphate linkage, and is part of
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Figure 3: A stem-loop. The stem-loop is an important and simple secondary structure that
RNA can form. It is a component of many larger RNA structures and is important in
various RNA recognition Sakurambo (2006)
recognition by the ribosome for translation, as well as to prevent 5’ RNases degrading the
transcript. Maturation also includes polyadenylation of the 3’ end of the mRNA. In this
process a number of adenine nucleotides are added to the mRNA to prevent degradation,
and to act as a signal to export the mRNA from the nucleus. Two cap-binding proteins
(CBP20 and CBP80) interact with the transcription/export complex to move mature mR-
NAs through nuclear pores into the cytoplasm Kierzkowski et al. (2009).
Once in the cytoplasm, the mRNA is recruited to the ribosome by the binding of eukaryote
initiation factors to the 5’ cap. During the initiation phase, the ribosome is assembled
around the mRNA, with the first transfer RNA binding to a 3 nucleic acid site called the
start codon. The ribosome translocates the mRNA by three nucleotides (one codon), and
the tRNA with an anticodon corresponding to the newly exposed mRNA codon binds to
the newly unoccupied A site. Simultaneously, the amino acid attached to the previously
resident tRNA is detached from the tRNA and added to the polypeptide chain that will
become the translated protein. This process is called elongation. Elongation continues until
the mRNA reaches a special sequence called the stop codon. The stop codon binds to a
unique protein called a release factor and signals the end of translation, and the ribosome
then releases the new protein.
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Transfer RNA Transfer RNA (tRNA) is a type of small RNA which holds an amino acid
and transfers it to the growing polypeptide during translation. tRNAs are typically between
76 and 90 nucleotides long and have a well conserved secondary structure Sharp et al. (1985).
tRNAs begin life transcribed in the nucleus from DNA, much like other RNAs. Some then
undergo splicing to remove introns, as well as extensive post-transcriptional modification
necessary to perform their mature function, for example, Human tRNA molecules have an
average of 13 modifications per cell Pan (2018a). The most abundant tRNA modifications
are pseudouridine and 5-methylcytosine. Modifications are known to effect tRNA stability,
localization, translation dynamics and ribosome binding. The tRNAs are then exported
from the nucleus and covalently linked with their requisite amino acid by their appropriate
aminoacyl-tRNA synthetase (an enzyme). Each type of tRNA has a three nucleotide long
site called the anticodon, which contains the complementary three nucleotides to the mRNA
codon for which it codes. At the beginning of the process of translating a mRNA into a
protein, the initiation complex forms starting with the small ribosomal subunit first, which
scans until a start sequence is found. The large ribosomal subunits is then recruited. The
initiator (Methionine) tRNA completes the complex. The ribosome contains three tRNA
sites. The initial Methionine starts in the middle (or P) site. Adjacent to the P site is the
A site, which during every step of translating one mRNA triplet to an amino acid, receives
a new tRNA matching the mRNA codon. The amino acid associated with this A site tRNA
is then bonded, via a peptide bond, to the one or more amino acids attached to the P
site tRNA, detaching the existing amino acids from the P site tRNA. Next, the ribosome
progresses three bases down mRNA, shifting the now amino acid free P site tRNA to the
E (or Exit) site, and shifting the A site tRNA with all of the attached amino acids into the
P site. The elongation process then repeats until a ”stop” codon is reached. Instead of a
tRNA binding to the stop codon, a special protein called a release factor binds to the A
site. Rather than add another amino acid, the release factor adds a water molecule to the
last amino acid and then separates the amino acid chain from the ribosomal complex. The
release factor then causes the disassembly of the ribosome-mRNA complex.
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Figure 4: The secondary structure of a typical tRNA. Note that many residues are modified
(in blue). tRNA is a heavily modified molecule, and the modifications are necessary for their
proper functioning. The three nucleic acid sequence at the bottom in red is the anticodon. It
contains nucleotides which are complementary to the codon for which it encodes. Yikrazuul
(2010)
MicroRNA MicroRNAs are an important class of short non-coding RNA that down-
regulate mRNA expression Lee et al. (1993). Mature miRNAs range in length from 19
to 25 nucleotides Bartel (2004), and are present in a wide variety of taxa across both the
plant and animal kingdoms Llave et al. (2002). miRNA undergoes a complicated series of
modifications between transcription and maturity . There are two major sources of miRNA.
The first is independent genes that only transcribe a primary-miRNA (pri-miRNA), and
miRNAs that are located in the introns of other genes. pri-miRNA biogenesis involves
several steps. After transcription, the RNA is processed in the nucleus through binding of
the Microprocessor complex Gregory et al. (2004). The Microprocessor complex contains
Drosha, a RNase III enzyme, and Pasha/DGCR8, a double-stranded RNA-binding domain
protein Han et al. (2004). Pasha recognizes the junction between the single-stranded flank-
ing region and the stem of the pri-miRNA and also interacts with the stem and terminal
8
Figure 5: MicroRNA is transcribed from the genome either as an independent pri-miRNA
or as part of an intron excised from another mRNA. If it is transcribed independently
as pri-miRNA it is processed by the enzymes Drosha and Pasha into a hairpin loop of
approximately 65 bases. If it is formed from an intron it is processed by a debranching
enzyme. The result of both of these actions is called a pre-miRNA. The pre-miRNA is then
exported from the nucleus by RAN-GTP and Exportin-5. The loop portion of the hairpin
is cleaved by Dicer. The two remaining strands dissociate, one forming the mature miRNA
and the other forming the miRNA*. The mature miRNA then is loaded into the RNA
induced silencing complex where it prevents translation of mRNA complimentary (in whole
or in part) to it. Narayanese (2012)
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loop. Pasha positions Drosha at the proper location for cleavage. Drosha then cleaves
the pri-miRNA producing two flanking fragments, and the ˜65nt stem loop region that is
called the pre-miRNA. Pre-miRNAs, are then exported from the nucleus by a RAN-GTP
dependent exportin called exportin-5. Once in the cytoplasm, pre-miRNAs are cleaved by
Dicer, a RNase III type protein. This cleavage removes the loop from the pre-miRNA and
produces a duplex of 22 nt miRNA. Of the two strands that were created by Dicer cleavage,
the strand with the more stable base-pairing at its 5’ end, called the miRNA*, is ejected
and then degraded in most circumstances. The mature complex, containing TRBP, Dicer,
the single strand of miRNA, and Argonaute, is called the RNA induced silencing complex
(RISC). Once RISC is assembled, the miRNA localizes the complex to the target mRNA.
In healthy organisms miRNAs are responsible for regulation of cell fate, changes in organism
life-cycle, and temporal regulation of development. The importance of miRNAs for normal
development has been shown by the fact that knocking out Dicer is embryonic lethal at an
early stage, causing the depletion of pluripotent stem cells. miRNAs also play a significant
role in disease. In cancer they can act as either oncogenes or tumor suppressors, dependent
upon what mRNA they target Shenouda and Alahari (2009).
Figure 6: The structure of the E. coli ribosome. The rRNA components are in darker red
and blue, with the protein components in lighter red and blue Vossman (2009)
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Ribosomal RNA The ribosome is a key part of the protein translation process. It con-
sists partially of proteins, as with most other enzymes; however, belying its ancient origin,
it also consists of structural RNA components. These components, known as ribosomal
RNA (or rRNA) have been known for the last 50 years to be highly modified Decatur and
Fournier (2002). The ribosome consists of two subunits identified by their size (in Sved-
bergs). In eukaryotes the large subunit is 60S and the small subunit is 40S Noller (1984).
In prokaryotes the large subunit is 50S and the small subunit is 30S.
The 50S subunit includes two RNAs, a 5S (˜120 nt in E. coli) and a 23S (˜2904 nt in E. coli)
and 34 proteins Green and Noller (1996). The important nature of modifications to these
rRNAs is apparent in the difficulty that the 23S rRNA has assembling into a functional
50S ribosome in vitro. In the absence of RNA modifying enzymes, 23S has great difficultly
reconstituting a catalytically active 50S subunit. Indeed, it suffers a greater than five orders
of magnitude decrease in this formation Green and Noller (1996). High resolution X-ray
crystallography shows that modifications to rRNAs occur in the regions which are most
closely linked to the proper functioning of the rRNA Chow et al. (2007).
1.3. Mass spectrometry
What is mass spectrometry Mass spectrometry is a complex of analytical techniques
that measures the mass-to-charge ratio of compounds in a sample El-Aneed et al. (2009).
By ionizing the analytes of interest, mass spectrometrists are able to use electromagnetic
fields to separate, contain, and measure their mass-to-charge ratio. Since any sample of
natural origin contains a small percentage of heavy isotopes of various atoms, the change
in mass (as well as the percentage of atoms which are of a heavier isotope Yergey (1983))
is well known, and since the change in mass is necessarily an integer, the change in mass
between the closest peaks in so-called isotopic clusters can then be used to calculate out the
mass of any particles of interest. Mass spectrometry takes advantage of properties inherent
to all forms of matter, because of this it is a widely applicable analytical technique, with
uses spanning biology, chemistry and physics.
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Figure 7: An example mass spectrum. The image is dominated by a set of isotopic peaks
corresponding to a charge 11 microRNA. The x axis is the mass to charge ratio (M/Z). The
y axis is the relative abundance of each mass peak, with the most abundant scaled to 100.
Since the distance between the closest peaks in the isotopic set is 1/11 m/z we can calculate
the actual mass of the analyte as 6791.9 Daltons.
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Figure 8: A schematic representation of the different locations at which RNA fragments
under higher-energy collision dissociation. The vertical bars in the left figure show where
the cleavage happens, and are annotated with a letter and a number in subscript denoting
the convention for annotating fragments. The letter represents the fragment type while the
number represents the number of nucleic acids remaining in the fragment. Additionally a-B
ions are formed with the cleavage of the base from the ribose on the 5’ side of the cleavage.
The figure on the right shows different fragment ion types are represented in so-called “fork
plots”.
What is tandem mass spectrometry? In addition to being able to measure the mass of
intact analytes, a form of mass spectrometry called tandem mass spectrometry (or MS/MS
or MS2) can be used to determine the mass of fragments of the analytes of interest. In
tandem mass spectrometry, a range of ions are selected by their mass to charge ratio and are
isolated using electromagnetic containment. This population of ions is then exposed to some
mechanism for breaking it down. While there are a number of different mechanisms available
on different instruments, the two types I used are higher-energy collision dissociation (HCD)
and collision induced dissociation (CID). HCD and CID both function by increasing the
kinetic energy of trapped ions using an electrical potential and then introducing a neutral
gas. The fast-moving ions collide with the slow moving neutral gas, converting some portion
of their kinetic energy into internal energy and breaking molecular bonds. By setting the
correct amount of energy to use in fragmenting the sample, the experimenter is left with
a population of fragments, ideally encompassing the total range of theoretical products.
This technique is useful on biopolymers, which are composed of a sequence of monomers
of known mass and have fragmentation patterns which are consistent and replicable. With
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a complete population of the potential fragments, we can then reconstruct a “ladder” of
peaks, each separated by the mass of the monomer present in one and absent in the other.
Through this method we can establish the complete sequence of the polymer. An example
of how this works for peptides is seen in the bottom right panel of figure 10. The arrows
labelled A, G, and L show the mass shift between successive amino acids.
In this work I will focus on the ability of mass spectrometry to measure biopolymers, which
has been traditionally applied to analyzing proteins, but which I will show is equally well
suited to analyzing RNA.
Proteomics, where we came from Proteomics is the study of proteins at a large scale
Bantscheff et al. (2012). It is a mature and well developed field with good software support
for mass spectrometry. Our lab’s expertise in proteomics is what has allowed for my rapid
entry into the field of nucleic acid mass spectrometry. In a standard proteomics pipeline
the workflow progresses from extracting proteins from the cell, to purifying them, and then
separating them along a chromatographic gradient. The liquid is then pushed out of an
emitter tip, while a voltage is injected into the liquid, creating charged droplets and ionizing
the peptides. Ionized peptides enter the mass spectrometer where they are detected by the
mass analyzer. Peaks of interest are then selected and fragmented to generate tandem
mass spectra. The spectra are recorded, and sent to the attached computer. Software is
then used to compare the experimental tandem mass spectra to theoretical mass spectra
in a library of known peptide fragments. The existence of software to automate hypothesis
testing is necessary to allow experiments which look at all known proteins for a species.
Even with current software there are still limitations in the scale of experiments which can
be done. Specifically, each addition of a potential modification increases the search space,
i.e. the potential number of solutions that need to be iterated through, exponentially. These
constraints make developing efficient, fast software both very necessary and very difficult to
do. Thankfully at this time most major mass spectrometer manufacturers have developed
solutions to handle at least modest sized proteomics data sets.
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Figure 9: An traditional example of a proteomics protocol. The general workflow is the
same as the one we use for analyzing RNA. The cells or tissues of interest are harvested, and
the proteins are separated out from the rest of the cellular components. If the experimenter
is curious about subcellular localization of proteins, further subdivision by cellular com-
partment follows. The protein mixture optionally is injected into a gel and undergoes gel
electrophoresis to separate out proteins of different mass. Gel electrophoresis can be skipped
if the experimenter in interested in multiple different proteins in the sample. The resulting
selected proteins are digested by a protease enzyme into short oligomers called peptides.
This digestion process makes both ionization and later identification of compounds easier.
The peptide mixture is separated by chromatography, allowing peptides of different mass
to reach the mass spectrometer at different times, and ultimately making identification
simpler. At the end of the chromatography column the separated peptides are ionized via
electrospray ionization. To accomplish this an electrical current is run through the liquid
containing the peptides, at the same time that peptides are forced out of a small spray tip
at high pressure. The combination of electrical repulsion from peptides of the same charge
and heat from the inlet of the mass spectrometer causes the peptides to form small drops.
Hupe´ (2012)
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Figure 10: These ionized peptides enter the mass analyzer and their mass to charge is
measured. Based on a set of predefined parameters masses of futher interest are selected
and collected for fragmentation. The fragments, called product ions, are injected into the
mass analyzer and their spectra are collected for analysis. The difference between successive
fragment masses can be used to establish the sequence of the peptide.
Chromatography: gotta keep ’em separated Samples of biological origin inevitably
contain a wide variety of different compounds. Separating these into manageable fractions
is an important step in any workflow involving such samples. Figure 9 demonstrates this.
Proteins are first separated through gel electrophoresis and then peptides are separated by
high performance liquid chromatography (HPLC).
HPLC turns out to be an incredibly useful tool for separating all sorts of different biological
molecules. It consists of a column containing an adsorptive solid stationary phase and a
liquid mobile phase that is a mixture of solvents which changes during the experiment. The
sample is loaded onto the column in a mixture called the loading buffer. The composition of
the loading buffer is such that the sample adsorbs to the particles of the stationary phase,
and will stick there no matter how much loading buffer is passed over them.
What happens next is dependent on what form of HPLC is being conducted. For the
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Figure 11: A flowchart of the components of this project. Nodes are colored based on a
general grouping of processes. Green are ex vivo (out of cells), red are analytical, and blue
are computational.
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purposes of this work, we will discuss what is called reverse-phase HPLC. In the standard
reverse-phase HPLC used in proteomics, the sample is loaded in an aqueous buffer onto a
stationary phase which is composed of a hydrophobic material. The hydrophobic peptides
bind strongly to the hydrophobic stationary phase. A mixture of solvents is then run over
the column at high pressure (>50 bar). The mobile phase starts out being predominantly
aqueous, and through the experiment the mixture transitions to containing more and more
organic components (acetonitrile is a common example hydrophobic solvent used in pro-
teomics). Depending on the chemical properties of the peptides bound to the stationary
phase, they will have a different affinity for the aqueous and organic phases. Because of
this they will be pushed off the stationary phase at different times during the experiment
i.e. at different proportions of aqueous versus organic phases. This separation by chemical
property is the core purpose of chromatography and allows the scientist to capture mass
spectra of different compounds at different times.
The chemistry of nucleic acids makes separating them by HPLC more challenging than
for peptides. Chemically, nucleic acids contain both hydrophilic and hydrophobic moieties
(i.e. parts), making the process of forcing them to adduct to a hydrophobic stationary
phase difficult. Traditional experiments that do not involve mass spectrometry typically
use cation-exchange chromatography Junowicz and H. Spencer (1969). Unfortunately, the
salts necessary to perform cation exchange are not compatible with mass spectrometry. The
good news is that there is a solution. The experimenter can add ion-pair reagents to act
as “adapters” and allow nucleic acids to bind to standard reverse-phase chromatography
columns Lin et al. (2007). Ion-pair reagents contain both chemical elements which are
hydrophobic and which are hydrophilic. The hydrophobic portion interacts with the sta-
tionary phase leaving the hydrophilic portion to interact with the hydrophobic phosphate
groups on the nucleic acid. In this manner it is possible to bind and separate different
nucleic acids by reverse-phase chromatography.
Unfortunately, adding ion-pair reagents has certain downsides. First, they are very difficult
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to remove from equipment (the HPLC, MS, and any tubing connecting them) once intro-
duced. For any porous or semi-porous surface they are functionally impossible to entirely
remove. Second, they suppress positive ionization in the mass spectrometer for as long as
they remain there, making sharing an instrument with a colleague who does ion-pair chro-
matography a trying ordeal at best. Lastly, even in the negative charge ionization mode
that we use for nucleic acid mass spectrometry, the ion-pair reagents partially inhibit the
electrospray ionization of the nucleic acids Gustavsson et al. (2001). This results in issues
keeping a stable spray from the electrospray tip as well as difficulties generating enough
signal in the mass spectrometer. Nonetheless (despite quite substantial testing) ion-pair
reverse phase HPLC remains the best technology for separating nucleic acids in a way that
is compatible with mass spectrometry, and it remains the method that I use throughout
this work.
Why do we care about RNA modifications? RNA is an extensively modified biolog-
ical macromolecule. Over 150 chemically distinct modifications have been reported, ranging
from simple methylation of the ribose or nucleobase to large additions such as the conversion
of guanosine to wybutosine. The presence of methylated adenine, cytosine, and guanine in
RNA was uncovered in the 1960s Borek and Srinivasan (1966), and pseudouridine has been
referred to as the fifth base for decades Davis and Allen (1957). However, widespread in-
terest in these epigenetic marks (primarily N6-methylated adenosine, m6A) has been raised
by recent reports that underscore their importance in a wide variety of developmental sig-
nalling. For example in stem cells, the intracellular effector proteins SMAD2 and SMAD3
promote binding of the m6A writer complex to a subset of mRNAs associated with early cell
fate decisions Bertero et al. (2018). Likewise, a number of modifications are associated with
disease. It has been demonstrated that the loss of taurine modification in the anticodon of
mitochondrial tRNA-Leu is responsible for mitochondrial myopathy, encephalopathy, lactic
acidosis, and stroke-like episodes (MELAS) Kirino et al. (2004). m6A is implicated in obe-
sity, as a target of FTO (obesity-associated protein, an m6A demethlylase) Jia et al. (2013).
The presence of m6A is also associated with increased injury-induced protein translation in
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adult mouse dorsal root ganglia. Loss of either m6A writer or reader results in defects in
functional axon regeneration Weng et al. (2018). Aberrant methylation of cytosine-5 (m5C)
in tRNAs has been linked to neuro-developmental disorders Abedini et al. (2018). The pro-
portion of the RNA which has been modified is also of interest. Frequently in tRNA’s for
example modifications may be present at a basal level but be expressed at an increased level
to increase their ribosomal affinity Pan (2018a). Being able to measure both the presence
and stoichiometry is thus important.
The recent interest in RNA epigenetics has been spurred by technical advances in next-
generation sequencing technology, which has allowed modifications in mRNA to be pro-
filed individually. All of the approaches based on next generation sequencing, such as,
Solexa/Illumina sequencing, use antibodies to immunoprecipitate modified RNA and/or
apply chemical treatments to alter it and read out modifications as mutations or trunca-
tions in the preparation of cDNA Li et al. (2016) Helm and Motorin (2017). The primary
caveat of these methods is that only a single type of modification can be profiled in each
experiment, and specific chemical and/or antibody reagents do not exist for every modifica-
tion. Further complications can be caused by lack of specificity of the existing antibodies,
in particular m6A and m6Am Linder et al. (2015). Antibody binding is, at best, a rather
inexact science. Cross reactivity abounds, and due to the stochastic nature of antibody
generation, there are many antibodies that work well for a given technique (e.g. western
blotting) but fail for other techniques (e.g. immunoprecipitation).
Tandem mass spectrometry is currently the only technique that can directly and compre-
hensively characterise chemical modifications in RNA sequences, by comparison of mass
spectra with a sequence spectral database Kullolli et al. (2014). Prior to the advent of
massively parallel (or next-generation) sequencing, there was substantial interest in using
mass spectrometry to sequence nucleic acids Apffel et al. (1997). However, these efforts
largely ceased as it became apparent that there were other sequencing methods available
that had greater throughput. As more and more of the biological relevance of modifications
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to nucleic acids has emerged over the last few years, there has been renewed interest in
using mass spectrometry for characterising modification. The majority of this work has
focused on reducing the RNA to mono-nucleosides and applying workflows analogous to
metabolite analysis Su et al. (2014). While these techniques are effective in determining
what modifications are present in a sample, all information about the location and co-
occurrence of modifications is lost. This information is critical in complex samples to allow
attributing modifications to specific RNAs. Even in simpler cases, modification location
and co-occurrence may be important for a phenotypic effect; for example, in microRNA,
2’-O-methylation of the 3’-most nucleic acid sterically inhibits 3’ exonuclease digestion (i.e.
prevents enzymatic breakdown of miRNA by 3’ exonuclease enzymes)Abe et al. (2014). For
this reason there is interest in analysing samples in as close to their native states as possi-
ble. However, intact oligonucleotides are challenging to separate via chromatography that
is compatible with mass spectrometry. The current approach of choice is reversed-phase
ion-pair liquid chromatography Huber and Oberacher (2001).
In addition to the experimental challenges, difficulties emerge in interpreting the acquired
data. Impressive steps towards automating data analysis have been made by several tools,
including SOS in 2002 Rozenski and McCloskey (2002), Ariadne in 2009 Nakayama et al.
(2009), Oma and Opa in 2012 Nyakas et al. (2012), and RNAModMapper in 2017 Yu et al.
(2017), all of which are database-matching scripts or programs that decode the complicated
patterns of oligonucleotide fragmentation. However, none of these existing software solutions
currently offers key features necessary to analyze data from large-scale experiments. First,
no software can efficiently handle RNA oligonucleotide spectral searches – especially of
more complex samples or involving many different modifications – in batch-compatible
fashion. Second, statistical validation strategies such as false-discovery rate estimation are
not implemented. This leads to unreliable sequence assignments and subjective manual
assessment of spectra for validation. Third, existing solutions do not tie into any larger
analytical framework, making integration with other (e.g. quantitative) data difficult. In
contrast, shotgun proteomics has been sequencing peptides reliably for many years, and the
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inference, identification and quantification of proteins from constituent peptides has been
automated to such a degree that the field has matured into answering biological questions
at a more fundamental level Gillet et al. (2016).
1.4. A roadmap
For this work, I used the standard proteomics experiment as a template, and adapted the
techniques for use with RNA. The initial target of my research was specifically focused in
looking at miRNA modifications. miRNAs are an ideal length for this work. They are
long enough to be unique, but short enough to be able to be effectively ionized in their
entirety. As the project has progressed, it has become apparent that both the analytical
method and the software are applicable to longer types of RNA as well. The development
of this project consisted of implementing a protocol to extract RNA from cells, as well as
a chromatography and analytical solution, and developing software to analyze the data. I
developed two generations of software during the period of this research. The results in
Chapter 2 were produced with the first pass software, and the results in chapter 3 come
from the final product. I describe the analytical portion of this project in chapter 2 and
describe the software portion of the project in chapter 3. Since creating meaningful data
from a sample of any complexity requires both the analytical and computational platform to
be worked out, the reader is advised that there is some crosstalk between the two chapters.
Chapter 2 also contains a brief discussion of the creation of a sheath spray assist device
for stabilizing the electrospray for nucleic acids. While this device did not end up being
used in the final iteration of the analytical method, it still is an important development
for which broader applicability is definitely possible. I continue to work on improving it
in the hopes of it being used in future experiments elsewhere. Chapter 3 will also discuss
some of the experiments that have been conducted to show both the proper functioning of
my method and to show its broad applicability to a variety of samples. It also contains a
brief description of work to use OpenMS’ label-free quantification techniques to assess the
stoichiometry of modifications. Chapter 4 concludes with a summary of where the field is
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after all of this work, and future directions in which the field can progress.
23
CHAPTER 2 : Analytical Methods and Analytical Challenges
2.1. Introduction
The first step toward being able to analyze mass spectrometry data is to generate mass
spectrometry data. Prior to developing any software, I needed to develop an analytical
system capable of producing data to analyze. In this chapter I discuss the trials and
tribulations involved in creating the analytical system, why nucleic acids are particularly
difficult to consistently analyze by mass spectrometry, and some of the ways to make them
easier to manage.
The analytical system that I developed consists of several parts. The first, extracting total
RNA from cells, was followed by separating RNA into fractions by length. Purification
was needed to further clean up the sample and reduce salt content (I discuss the challenges
associated with this step later in this chapter). The complex mixture of RNA then needed to
be separated in such a way as to limit the number of RNA species in single MS1 (i.e. parent,
or full) scans, and the subsequent potential for missing triggering MS2 (i.e. daughter or
dependent) scans in a timely fashion. After the separation, the RNA needed to be ionized in
order to be visible in the mass spectrometer. I will start by discussing the chromatographic
separation, the ionization, and the mass spectrometry. I will then move on to looking at
my early experiments to determine the sensitivity of my system, and its ability to separate
mixtures containing multiple different RNAs.
The analytical system that I used to separate different RNA went through several phases.
Initial attempts to directly inject samples containing only a single RNA using the Triversa
Nanomate device were unsuccessful. I then moved to using ion pair reverse phase chro-
matography, both to separate different species of RNA in the same sample and to separate
RNA from non-RNA contaminants in the same sample. A substantial amount of time was
spent adjusting the buffer composition to produce consistent results. In order to offset
the disadvantages inherent in needing to use ion-pair reagents, I developed an axial sheath
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spray assist device to improve spray stability. While the addition of this device substantially
improved my results, it ended up being complicated to run. Thus I ultimately moved to a
system based off of Thermo Fisher EASY-Spray columns.
The reasoning for choosing miRNA (analogues) for the initial analytical work was twofold.
First, the length (and therefore mass) of miRNA is constrained to a length which is within
the mass range of the instruments that I use. That is, I do not need to do any further
digestion to create fragments of an analyzable length. The second reason is more complex;
recent work has shown that miRNAs can contain a variety of modifications that affect their
function. These include base additions like uridylation, as well as modifications to existing
bases and sugars. A particularly well characterized modification is the addition of a methyl
group to the 2’ oxygen on the ribose of the 3’ nucleotide of the miRNA Abe et al. (2014).
In both Drosophila and Arabidopsis it has been shown that this addition changes the shape
of the 3’ end of the miRNA, slowing the activity of 3’ exonucleases, therefore increasing
the lifespan the molecule Li et al. (2005). Oxidation by reactive oxygen species is another
modification that has been linked to increasing the inhibitory activity of certain miRNA
species in cardiac ischemia Wang et al. (2015).
2.2. Experiments
2.2.1. Chemicals
Chemicals used for HPLC were: Triethylamine (TEA), Hexafluoro-2-propanol (HFIP),
methanol, HPLC grade water, Ethylenediaminetetraacetic acid (EDTA), HPLC grade ace-
tonitrile. Synthetic miRNAs were ordered from Integrated DNA Technologies (IDT). These
included dme-miR-34 (UGGCAGUGUGGUUAGCUGGUUGUG), dme-let7 (UGAGGUAGUAG-
GUUGUAUAGU), and dme-BANTAM (UGAGAUCAUUUUGAAAGCUGAUU). Variants
of miR-34 and let7 were also ordered with a 2’-O-methylation on the 3’ terminal nucleic
acid. MiR-34 was additionally ordered with a 2’-O-methylation on the 5’ terminal nucleic
acid. All synthetic miRNA samples were HPLC purified by IDT. I chose these three RNA
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analogues as they correspond to miRNA that have been well studied. A schematic of the
liquid flow in my instrumentation is provided in figure 12.
2.2.2. Direct infusion with the NanoMate
The Triversa NanoMate is a chip-based electrospray ionization device which allows direct
infusion of very small quantities of sample through a chip-based nozzle and into the mass
spectrometer. It is an ideal piece of equipment for analyzing relatively pure simple samples,
and is faster and requires less setup than chromatography. It also compares favorably
to traditional direct infusion from a syringe in that it allows the use of substantially less
sample and substantially lower flow rates (which correspond to higher ionization efficency
and minimizing reagent usage). Since nucleic acid mass spectrometry requires ionizing in
negative mode, I had to deal with the associated challenges of producing a stable spray
without arcing over the very small distance between the chip and the ion capillary. In my
initial experiments I varied the composition of the liquid in which I suspended the nucleic
acid oligomers from 100% water to 100% acetonitrile. Unfortunately, what I found was that
as the acetonitrile concentration was increased the stability of the spray improved, but the
suspension of the nucleic acid became more tenuous. This resulted in a series of experiments
which showed that I could either get spray for a very short period of time followed by the
nucleic acid precipitating and clogging the spray nozzle, or I could have a higher percentage
of water, preventing precipitation but also preventing a spray that was stable enough to
collect data from. Given these competing constraints, I determined that the NanoMate was
not an ideal solution for oligonucleotide mass spectrometry.
2.2.3. nanoLC-MS/MS
The HPLC system that I used consisted of an Eksigent AS2 autosampler and an Eksigent
NanoLC-Ultra 2D+. The preliminary experiments were performed on a Thermo LTQ, with
the majority collected on a Thermo Velos Orbitrap-LTQ. On the Orbitrap instrument, both
MS1 and MS2 spectra were collected using the Orbitrap, a high resolution mass detector,
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Figure 12: A schematic of the instrumentation used in the nano-LC system. The sample is
loaded from vials in the autosampler by the syringe. The autosampler valve then switches,
putting the loading pump in line with the loaded sample. The loading buffer is pushed
from the loading pump through the HPLC valve and into the HPLC column. This flow
pushes the sample onto the column where it sticks. Once loading is complete, the loading
pump shuts off and the HPLC valve rotates, putting pump 2 in line with the column.
Simultaneously the Orbitrap energizes the emitter tip, starting electrospray and starting
to acquire spectra. Pump 2 begins running mostly buffer A (the aqueous buffer), and as
the experiment progresses the amount of buffer B being pumped increases, causing the
nucleic acids on the column to elute off when the percentage of organic solvent reverses
their adduction to the column. Note that this diagram describes a one column setup. For
some experiments I also added a trap column before the main column allowing sample to
be loaded to the trap column with a much higher flow rate than the main column could
tolerate.
27
with resolution of 30,000 or 60,000. Fragmentation was performed by collision induced
dissociation (CID) with a normalized collision energy of 35, an isolation window of 1 m/z
(mass to charge) and isolation time of 10 ms. Synthetic miRNAs were diluted to 1uM,
100nM, 10nM, and 1nM by the addition of HPLC grade water containing 1mM ethylene-
diaminetetraacetic acid (EDTA). The addition of low concentration EDTA was observed
to both increase column longevity as well as decrease salt adduct formation. Samples were
loaded from the autosampler using an aqueous loading buffer containing 100 mM HFIP, and
1.7mM TEA adjusted to pH 7.5. Samples were loaded onto a 5cm X 100 µm trap column
containing 3µm C18-aq resin. Loading to the trap was accomplished using the same 100
mM HFIP and 1.7mM TEA buffer that was used in the autosampler, at a rate of 3uL/min
for a duration of 10 minutes. The longer loading period allowed for better removal of the
EDTA and any attached salts. Following loading, the sample was eluted into the MS on a
60 minute gradient with buffer A being the same as the loading buffer, and buffer B con-
sisting of 90% methanol and 10% acetonitrile. The analytical column used was a 75µm ID
x 15cm C18-aq column packed in-house, attached to a 10µm electrospray tip (also packed
with C18-aq, to minimize bubble formation from pressure drop after the column). Analysis
was performed over a 60 minute gradient at 250nL/minute with the following profile: 0-12
minutes: 95.2% A, 12-15 minutes: 95.2% to 90% A, 15-42 minutes: 90% to 64.8% A, 42
to 43.5 64.8% to 30% A, 43.5-52.5 minutes 30% A, 52.5-54 minutes 30% to 95.2% A, 54-60
minutes 95.2% A. ESI voltage was set at -1.8kV and the capillary temperature was set at
180C◦. I performed these experiments in negative mode MS, as the phosphate backbone is
not amenable to ionization in positive mode. To separate different oligonucleotides, I used
ion-pair reverse-phase liquid chromatography. In order to achieve a level of sensitivity that
will allow detection of miRNAs from cell samples, I use nanoflow conditions (250nL/min).
Performing chromatography at a lower flow rate increases the proportion of ions which are
analyzed by the MS, and improves sensitivity compared to a higher flow rate. The sys-
tem was flushed out using a wash-cycle between sessions and after every 6 runs. In most
runs, MS1 profile data was recorded in the range of 520-1200 m/z (effectively filtering out
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the lower m/z background produced by HFIP). I also acquired data spanning 520-850 m/z
and 520-1800 m/z in my preliminary experiments. Spectra were recorded using Thermo’s
acquisition software Xcalibur.
2.3. Results and Discussion
Figure 13: A micrograph of an electrospray tip which has been coated in salt.
Handling salt Salt is a major issue for mass spectrometry. It inhibits ionization and has
a nasty tendency to build up at the spray tip. This issue is much more pronounced with
nano-flow chromatography due to an increase in the surface area to volume ratio of the
spray tip to the flow. As the spray tip radius decreases, the flow cross section decreases at a
quadratic rate while the inner circumference of the tip decreases at a linear rate. This leads
to a larger portion of the flowing liquid directly contacting the silica that makes up the tip.
In my experiments, this resulted in salt crystal formation at the spray tip disrupting proper
spray cone formation and ultimately blocking the system entirely. In early work I simply
switched tips regularly, however the stochastic nature of this type of salt failure required
an operator constantly keeping an eye on the instrument throughout the run. I found that
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despite the claims from the synthetic oligonucleotide manufacturer that all products were
HPLC purified, there was still substantial salt remaining in their nominally pure samples.
To counteract this salt contamination, I used STop And Go Extraction (STAGE) tips to
flush out as much of the salt as possible Yu et al. (2014).
RP-Ion-pair HPLC separates different miRNA sequences at the nanoflow scale.
The majority of previous work on RNA MS has been performed using micro-flow chro-
matography. Using a nano-flow system allows for better sensitivity and smaller sample
requirements. In this work, I demonstrate the capability of nano-flow MS/MS to accu-
rately identify oligonucleotides. I am able to separate different oligonucleotides to allow
individual identification of oligonucleotide species using nano-flow ion-pair reverse phase
chromatography. Using my nanoLC-MS/MS platform, I was easily able to detect a clear
chromatographic peak for the synthetic oligonucleotide Let-7, at low nanomolar concen-
trations (figure 14a). Mass spectra obtained on a Velos Pro Orbitrap instrument of the
oligonucleotide showed a large variety of charge states (figure 14b). However, high resolu-
tion MS acquisition did demonstrate the presence of a series of salt adducts (K+ ions) on
the oligonucleotide (figure 14b inset). Nonetheless, I was still able to acquire high-quality
CID MS/MS scans, with fragment ions spanning the entire Let-7 sequence, demonstrating
that I can distinguish between the extensive number of fragments that are created during
MS2. (figure 14c). A demonstration of the output of the data processing step is seen in
figure 19, which shows identifications (green boxes) of different charge states of Let-7 at
picomole quantities.
One challenge I faced while optimizing these nanoLC-MS/MS methods was inconsistency
in nanospray stability and quality. Salt build-up on the spray-tip further impaired spray
stability and necessitated frequent replacement of the tip, and prevented me from effectively
using fritless columns with integrated tip. Initially, I used commercial columns to perform
separation; however, these columns needed to be replaced frequently because of clogging.
To gain more control over the quality of spray and reduce costs, I pulled and packed columns
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Figure 14: a) Chromatogram of Let-7, b)Mass Spectrum of Let-7 showing the same analyte
at multiple charges. Inset shows the details of the analyte with varying number potassium
adducts. Close examination shows the isotopic peaks. c) Tandem mass spectrum (CID) of
Let-7, annotated by hand to show identified fragments of Let-7. RNA fragmentation pro-
duces a wider variety of fragment ion than peptide fragmentation, making annotation more
difficult. Schema at right shows possible fragments, and sequence ladder shows detected
fragments.
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“in-house” specifically for nucleotide work. Using a 2-D HPLC with two gradients available
has also allowed me to improve column life and provide more consistent results by including
a “wash-cycle” with a simple aqueous (100% H2O) to organic (90% MeOH) gradient, after
every 5 runs and at the end of an experiment. I found the addition of this step also
decreased column back-pressure after a full cleaning cycle. The addition of a wash run
omitting ion-pair reagents and cycling from 5% organic to 90% organic over 30 minutes has
also decreased the incidence of clogging in the spray tips. I have also seen an improvement
in signal, and a decrease in adduct formation by reducing the concentrations of ion-pairing
reagents used in previous micro-flow work Lin et al. (2007). Nucleotides commonly form
adducts with sodium or potassium ions, which decrease the total ion signal for the analyte
and can damage the instrument (figure 14b). At the start of the method optimization, I
saw significant adduct peaks, which I was able to suppress by adding 1mM EDTA as a
chelating agent. The EDTA and attached salts were then washed out during the loading of
the trap column.
2.3.1. Spray assist device
Working with negative mode ESI-MS is challenging, doubly so with the addition of ion-pair
reagents. I found that in order to achieve consistent signal stability, it was necessary to
modify an existing source to introduce sheath gas (that is, a gas introduced around, and
in the same directions as, the electrospray tip). I followed existing research into adding a
non-inline mixture of an inert gas and an organic solvent Huber and Krajete (2000). My
experiments showed that adding the nebulized sheath liquid inline with the spray tip would
require a less complicated hardware setup, as well as providing a more consistent distribution
of the nebulized liquid around the tip. Design of the device took several iterations, with
attention paid to minimizing the difficulty of setup and achieving an even mixture of liquid
and gas. This mixing proved an engineering challenge, since commercially available parts
for chromatography were either designed for gas or for liquid. The current device uses a
commercially available mixing tee coupled to a check-valve to prevent back-pressure from
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Figure 15: Schematic of the experimental setup including the sheath spray device. Sheath
liquid, Acetonitrile in my experiments, is pumped from a syringe pump. Nitrogen flows from
a high pressure ultra high purity nitrogen cylinder and flows through a pressure regulator.
Gas and liquid mix in small diameter PEEK tubing to ensure an even gas liquid mixture.
Voltage for electrospray is injected via an electrode between the column and the electrospray
tip.
the gas side displacing liquid.
A custom built nano-ESI source was assembled to fit on a Thermo Orbitrap Classic. At-
tached to the source was a capillary containing a mix of nitrogen pumped from a gas
cylinder, and Acetonitrile pumped by a HPLC pump. This mixture was then pumped into
a tee containing the fused-silica electrospray tip. Flow from the analytical column entered
the back end of the spray tip at a junction prior to the tee. The front end of the electrospray
tip protruded out the opposite end of the tee, surrounded by a larger sheath capillary which
provided space around the tip. I measured spray stability of nucleotides with and without
sheath flow, as well as the signal produced in an Orbitrap mass spectrometer.
To assess spray stability across a range of sheath gas and sheath liquid conditions I attached
syringe filled with standard calibration mix (calmix) to a pulled silica capillary. The capil-
lary was inserted into the spray assist device, with the tip of the pulled capillary protruding
approximately 1mm from the sheath capillary. The combined device was then attached to a
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Figure 16: A graph showing the average intensity of the peaks for three different substances
in the calibration mix, m/z of each are shown in the legend. Sheath gas pressure was
measured at the regulator, and no sheath liquid flow was applied for this experiment.
Intensity units on the Y axis are arbitrary but internally consistent in the instrument Error
bars show the standard deviation between scans in average intensity.
Thermo Fisher Orbitrap LTQ. The spray voltage was set to 1.5kV and the syringe flow was
set to 500nl/min. Sheath gas pressure was tested at 0, 10, 20, 30, 40, 50, 60, and 80 psi as
measured at the gas regulator. Sheath liquid flow was set to 0 for these experiments. Next I
set the sheath gas at 30psi (the setting I had used for nucleotide data acquisiton) and varied
the sheath liquid flow to 250nl/min, 500nl/min, 1000nl/min, and 2000nl/min while holding
the gas pressure steady at 30psi. I recorded data in FTMS mode for 60 seconds in each of
the experimental conditions. Using in house software derived from OpenMS’ EiceExtractor
I measured average peak height, max peak height, total peak area and intensity variance
at three different masses over the 60 second run. The masses chosen (265.25, 514.5 and
1579.83) were selected as being particularly abundant, and representing a wide range of
m/z.
By all three metrics (average intensity, max intensity, and total peak area) the addition of
sheath gas (independent of sheath liquid) significantly improved the signal. Interestingly
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Figure 17: A graph shows the relationship between varying sheath liquid (actonitrile) flows
and average peak intensity for the same three analytes as in the above graph. Sheath gas
flow was held constant at 30PSI across all of the different liquid flows.
enough, in these experiments I saw a continued improvement in signal intensity as gas
pressure was increased. This is in contrast to my previous experiments assessing signal
stability using synthetic oligonucleotides, where increases in gas pressure above 40psi did not
improve stability and appeared to be detrimental. I hypothesize that there is a link between
the significantly greater size of the oligonucleotides (6000-8000 daltons) as compared to the
calmix compounds decreasing their ability to be sufficiently ionized at higher gas flow rates.
The varied sheath liquid flow experiments also showed significant improvement in aver-
age intensity, max intensity and total peak area upon the introduction of sheath liquid to
the device. In contrast to my gas-only experiments, I was able to find a maximum signal
improvement at 500nl/min. Visual inspection of the spray tip showed an increase in liq-
uid gathering at the sheath capillary tip when the liquid flow was increased to 1000 and
2000nl/min. I hypothesize that increasing the ratio of sheath liquid to sheath gas above a
critical limit prevents even mixing of the liquid and gas, resulting in a decreased positive
impact on analyte signal. Further experiments will be necessary to determine whether or
not there is a consistent critical ratio above which sheath liquid is detrimental.
35
Figure 18: A picture of an early iteration of the coaxial sheath spray assist device.
Another open question is whether the optimal sheath liquid and gas settings are dependent
on the m/z of the compound. In my experiments with adjusting sheath liquid, the higher
m/z analyte shows much more improvement (4.06-fold) at a sheath liquid flow of 500nl/min
than the lowest m/z compound (1.75 fold). I hope to expand my experiments to include a
wider variety of m/z compounds to determine whether this trend holds. In my sheath gas
tests, I did not observe a clear trend in fold intensity increase dependent on m/z. Additional
future work is needed to confirm or deny this independence.
My sheath spray device offers substantial improvement to analytes run in negative mode
nano-flow mass spectrometry. I demonstrate this qualitatively by looking at my improved
ability to observe oligonucleotides, as well as quantitatively in my assessments of the calmix
compounds at a variety of sheath gas and liquid flows.
I can distinguish modified and unmodified nucleic acids. Using my sheath spray
assist device along with reverse-phase ion-pair chromatography, I am able to differentiate
between different miRNA sequences and between methlyated and unmethylated species
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Figure 19: Identified miRNAs and features displayed over a 2d representation of an MS
experiment using OpenMS’ TOPPView. The X-axis is retention time, and the Y-axis is
m/z. Intensity of peaks is represented by color. Blue rectangles are sets of peaks identified
by the featurefinder algorithm. Green rectangles are features with an assigned identification.
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observed across the m/z range collected by the Orbitrap. The observable charge states of
the miRNAs are between negative 6 and negative 15. The resolution on the instrument was
sufficient to distinguish between m/z differences as low as .01 dalton, which is high enough to
differentiate between methylated and unmethylated sequences. Figure 20 demonstrates the
clear separation of the methylated and unmethylated forms of the oligonucleotide. Panel 20a
shows separation in both retention time (x-axis) and m/z (y-axis) between the two labeled
green identified features, panel 20b shows the chromatograph demonstrating separation of
retention time, and panel 20c shows the shifted peaks in the mass spectra of the methylated
form compared to the mass spectra of the unmethylated form.
I can achieve sufficient coverage of the fragment spectra of nucleic acids to be
able to definitively identify individual nucleic acids. In contrast to peptides, which
produce predominantly two types of ions during fragmentation, nucleotides can produce up
to nine different fragmentation types with varying abundances. Figure 21 demonstrates the
complexity that this generates. The MS2 spectrum shown is 3’ 2’-O-methylated Let-7 all
of the peaks corresponding to fragments of the oligonucleotide are labeled, and a ladder
of identifications is shown in the inset. Starting out in this project I generated a list of
theoretical fragments for a given RNA sequence using the web-applet MongoOligo1. I then
progressed through most abundant MS/MS spectrum, or spectra, from the experiment
and hand annotated peaks which matched the theoretical fragments. This process was
arduous and so for the later part of this work, I developed a theoretical spectrum generator
to produce model fragments for nucleotides, and score their matches to the experimental
spectrum, to produce a score for all potential assignments. This work can be seen in my
NucleotideID node for OpenMS2 . In both manual and software alignments, I am able
to identify enough fragments to identify between different sequences of miRNA. Identical
sequences modified at different locations cannot be distinguished by parent mass alone.
1http://mods.rna.albany.edu/masspec/Mongo-Oligo
2https://github.com/poshul/OpenMS/tree/feature/calculate RNA masses
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Figure 20: Separation between 2’-O-methylated and unmethylated Let7. A) A two di-
mensional view of the experiment. X-axis is retention time, and y-axis is m/z. Potential
features are marked as blue boxes with each line outlining an isotopic peak in successive
scans. Identified features are marked in green. B) Selected chromatograms and C) spectra.
Separation between unmodified and modified species is noticeable in both retention time
and m/z.
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Figure 21: MS2 spectra of 3’ 2’-O-methylated Let7. Identification ladder is inset. There
are at least two different ion types detected at each position in the sequence, showing good
and confident annotation.
I am able to detect oligonucleotide presence down to a concentration of 5 fem-
tomoles per sample. I generated samples of my synthetic oligonucleotides with 1pMol,
500fMol, 100fMol, 50fMol, 10fMol, 5fMol and 1fMol each per sample. From these serial
dilution experiments I can confidently detect oligonucleotide presence as low as 5fMol per
sample. This corresponds to a signal to noise ratio of at least 4. I hope to continue improv-
ing my spray stability to increase my ability to detect even at lower concentrations. Future
work identifying oligonucleotides at low concentration will likely be aided by limiting my
detection programs to identifying peaks with high charge states.
2.4. Conclusions
I have developed a functional platform which helps automate the computational analysis
of oligonucleotides. Through innovations in both my laboratory methods and my updated
software, I am able to separate and identify a variety of oligonucleotides. This work has
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Figure 22: Features generated from the same 1pMol let-7 experiment data file using: a)
feature selection using builtin average isotope distribution model (averagine). b) feature
selection using user-defined RNA averagine. Since the atomic composition of nucleotides
is substantially different than the atomic composition for amino acids, many valid feature
identifications are discarded by the algorithm for not matching the predicted isotopic abun-
dance. Providing the algorithm with a corrected average monomer composition results in
much better selection of both let-7 (green boxes), and a mono-adducted form (blue boxes
above the green in b).
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shown that I can use MS to effectively identify nucleotides in low level quantities to be
worthwhile for use in the analysis of small non-coding RNAs in general and miRNAs in
specific. Continuing this research, I will work on identifying modifications that have not been
seen before on miRNA. I also see potential applications of the software I have developed to a
wide range of nucleic acid analysis, including but not limited to exploring DNA methylation
products and characterizing natural modifications in viral genomes.
The initial setup this system required specialized equipment and expertise, as my experi-
ments have progressed I have been able to simplify the lab setup. Moving to the EASY-
Spray column and source has been the largest step toward this, allowing this method to be
conducted with commercially available equipment.
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CHAPTER 3 : Development and testing of the Software platform
3.1. Introduction
The computational portion of the platform went through two distinct phases. In the first,
I used a feature detection based approach to select which sets of peaks were likely to be
RNA. This approach worked well in testing with simple samples, and was very useful in
the development of the analytical method (as described in chapter 2), however the time
taken to search more complex data sets (such as the ones discussed later in this chapter)
quickly became prohibitive. I then reevaluated whether to use parent or daughter (that is
MS1 or MS2) spectra to identify whether a peak was nucleic acid or simply a look alike.
Switching to searching for MS2 spectra with parent masses which were feasibly nucleic acids,
and then looking at their parent spectra greatly decreased search complexity, and allowed
the final tool (NucleicAcidSearchEngine) to be much faster, making analysis of biological
samples feasible. In this chapter I discuss the development of NucleotideID and the later
NucleicAcidSearchEngine (NASE).
3.2. Methods
3.2.1. Data Processing with NucleotideID
Raw files from Thermo Fisher’s mass spectrometry software suite Xcalibur were converted
to the open and standardized MzML format using MSConvert (a component of ProteoWiz-
ard1). I detect, group and quantify the mass traces of eluting (oligo-)nucleotides using a
feature detection algorithm. I build upon an existing algorithm originally developed for
label-free and labeled proteomics data available in the OpenMS framework for computa-
tional proteomics and metabolomics Rost et al. (2016). In order to make it applicable
to (oligo-)nucleotides, I extended both parts of the OpenMS core library as well as the
FeatureFinderMultiplex tool to support the characteristic isotopic envelopes (i.e. the
ratio of heavy to light isotopes characteristic of the sample) of (oligo-)nucleotides in the
1http://proteowizard.sourceforge.net/ version used:3.0.4833
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Figure 23: A schematic of the computational workflow. Nodes are referred to by their
number in the upper left. 1) Input FASTA file, contains all of the known miRNA sequences
source species of the sample. 2) Input mzML file, the MS experiments. 3) FeatureFin-
derMultiplex, takes a MS experiment as input, locates and annotates peaks as features
which are likely the signal from Oligonucleotides, and outputs the detected features. 4)
NucleotideIDAMSDBCreator transforms the input FASTA sequences into a database used
by AccurateMassSearch. 5,6) Merge the two outputs from 4 into 8. 7) HighResPrecursor-
MassCorrector, takes the features from 3, and the experiment from 2, and corrects the m/z
of peaks within each feature. 8) AccurateMassSearch annotates MS1 features with miRNA
sequences that match the feature’s mass. A list of putative modifications are stored in
output 10. 9) NucleotideID, takes the corrected MS experiment and annotated features as
input. Theoretical MS2 spectra are generated for each miRNA identified in 8, and compared
to experimental tandem mass spectra. The results are scored and stored in output 11.
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detection process. FeatureFinderMultiplex performs a filtering step to detect isotopic
envelopes in single spectra, a clustering step that combines isotopic clusters over the chro-
matographic elution, and an (optional) linear fitting step required to determine relative
quantification for isotopically labeled data. Since the experiments did not involve isotopic
labeling, the linear fitting step was disabled by configuring the tool to perform label free
analysis.
Several properties determine if mass peaks are considered part of an isotopic envelope of
an analyte. For one, a user-specified minimum number of isotopes with intensities above
a specified threshold is required. For another, the relative intensities of the isotopic peaks
need to agree with a theoretical average monomer model (averagine). Averagine is a model
of the average elemental composition of a theoretical monomer (single amino or nucleic
acid). Previous to this work, the averagine model was fixed to proteomics data. I added a
user definable parameter to define the averagine model to use for feature selection. Since the
atomic composition of amino acids and nucleic acids differ, this addition greatly improved
feature detection. The clustering step groups the data points in the isotopic envelopes over
retention time, using a hierarchical clustering algorithm. The intensities of each group of
data points are summarized into a single abundance value. This abundance value along
with the mass traces of the analyte form a feature.
Feature identification, i.e. annotating a nucleotide sequence to each feature, was performed
using existing tools of the OpenMS framework. Identification of each spectrum was done
using a two-step process. First, the parent ion mass was compared to all possible miRNA
masses for the species of interest (Drosophila melanogaster) based on a library created
from a FASTA file using the NucleotideIDAMSDB tool. The AccurateMassSearch tool in the
OpenMS framework compares the mass of each feature to all of the masses of the miRNAs
in a user supplied database, and for each match, the feature is annotated with a candidate
sequence. In the second step, this list is passed to another tool which generates a spectral
library of theoretical fragment spectra based on the previously determined candidates. The
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theoretical fragment spectra were then compared to the experimental MS2 spectrum us-
ing the OpenMS spectral library search tool MetaboliteSpectralMatching. The highest
matching score is reported as best fit. More information about the tools in OpenMS and
their parameters can be found online at http://ftp.mi.fu-berlin.de/pub/OpenMS/release-
documentation/html/index.html. See Figure 23 for details of the NucleotideID workflow.
Improvements to the feature finding algorithm drastically improve feature iden-
tification for oligonucleotides. The OpenMS FeatureFinderMultiplex algorithm re-
lies in part on a comparison between the experimental and theoretical isotopic distributions
for a molecule. The algorithm was developed for use with peptides, which have a character-
istic average monomer mass, or “Averagine”. Since the atomic composition of nucleotides
varies significantly from that of peptides, the theoretical isotopic distributions that the fea-
ture finder produced do not match experimental distributions. By adding a parameter to
define the atomic composition of the theoretical average nucleotide monomer, I have been
able to improve the definition of the theoretical isotopic envelope, thereby enhancing identi-
fication of nucleic acid features in the data. This can be seen in Figure 22, where panel 22a
demonstrates the low number of identifications generated using a feature finder with the
incorrect isotope settings. Panel 22b shows the results of the same feature finder algorithm
but with the correct isotope settings. Many more features are detected (blue boxes) and
identification of the nucleotide is successful (green boxes).
Given the relatively limited number of miRNAs for a given organism (˜2000 in humans
Hammond (2015)), the database-based approach works well at unambiguously identifying a
given oligonucleotide. Unlike the large size of the proteome, the search space for a miRNA
is much smaller, allowing the identification approach to be extremely successful in defini-
tively identifying the miRNAs despite their more complicated fragmentation profiles. The
comparatively small search space also makes a combinatorial approach to identifying mod-
ifications possible; a modern desktop computer has the power to search experimental data
against all known RNA modifications for all known miRNAs.
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3.2.2. Data Processing with NASE
Here, I present my work on creating a fast, scalable database-matching tool called
NucleicAcidSearchEngine (NASE) for the identification of RNA oligonucleotide tandem
mass spectra. This new software was developed within the OpenMS framework. NASE will
be fully integrated into the primary distribution of OpenMS in the upcoming version 2.5,
and will then be accessible to interested users who download the software from the website
(https://www.openms.de). In the meantime builds of NASE in the OpenMS framework are
available at https://www.openms.de/comp/nase/.
The field has an urgent need for enhanced RNA characterization tools. The field of pro-
teomics has been able to advance rapidly in large part due to its ability to analyze data
in a consistent and rational manner. Proteomics has been able to take advantage of an-
other important feature of mass spectrometric data: it is inherently quantifiable, making
it able to be compared between different conditions in the same experiment. The software
which I introduce here also enables this, making it the first nucleotide mass spectrometry
solution to enable label-free quantification of data based on MS feature integration. Here I
demonstrate in three different case studies that my software, NASE, is capable of reliably
identifying a variety of RNA types from different sources.
3.2.3. Liquid chromatography-tandem mass spectrometry
All of the RNA samples in these experiments were separated by reversed-phase ion-pair
liquid chromatography (using 200 mM HFIP + 8.5 mM TEA in H2O as eluent A, and
100 mM HFIP + 4.25 mM TEA in methanol as eluent B) and characterised by negative
ion MS/MS in a hybrid quadrupole-orbitrap mass spectrometer (Q Exactive HF, Thermo
Fisher). A gradient of 2.5 to 25% eluent B eluted oligonucleotides from various lengths of
nanoflow Acclaim PepMap C18 solid phase (Thermo Fisher) at 200 nL/min. The length of
gradient was varied according to the complexity of the sample. Precursor ion spectra were
collected at a scan range of 600 to 3500 m/z at 120k resolution in data-dependent mode,
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with the top five MS1 species selected for fragmentation and MS2 at 60k resolution.
3.2.4. RNA samples
A variety of RNA samples were characterised by nanoflow LC-MS and sequence analysis
performed using NASE. Initial work was carried out on a mature Drosophila let-7 sequence
that was prepared by solid-phase synthesis. This sequence is a 21nt long microRNA that
was among the first miRNAs to be characterised Reinhart et al. (2000). The RNA was
chemically synthesised in unmethylated and methylated forms (with or without a 2’-O-
methyluridine (Um) at position 21). A sample was prepared by mixing both forms, and
was characterised by nLC-MS without further processing, but with varying normalised
collision energy (NCE) settings to give different levels of precursor fragmentation.
Subsequent experiments were carried out on NME1, a 340 nt long Saccharomyces lncRNA.
NME1 RNA was generated by in vitro transcription, and two samples with and without
NCL1 enzyme treatment were prepared. NCL1 is a yeast RNA methyltransferase that
catalyses the 5-methylcytidine (m5C) modification Motorin and Grosjean (1999). RNA
was extracted and digested with RNase T1 prior to nLC-MS. This endonuclease generates
shorter oligonucleotides by cleaving immediately after guanosine residues.
The most complicated sample was a solution of digested crude human cellular tRNA, which
was isolated from HAP1 tissue culture using an RNeasy kit (Qiagen) as according to the
manufacturer’s instructions. Briefly, RNAs can be fractionated by length by differential
elution, with RNAs less than 200 nucleotides mostly made up of tRNA, and the larger
fraction being mostly rRNA. The shorter RNA fraction was digested with RNase T1, and
the resultant oligonucleotides were characterised by nLC-MS.
In all cases of internal RNA digestion by RNAse T1, oligonucleotides are generated with a
5’ OH and a 3’ phosphate. In the RNA sequence notation used throughout this paper, a p
at the end of a sequence represents the 3’ phosphate.
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Sequence database searches For NASE analyses, all proprietary raw files were con-
verted to mzML format Martens et al. (2011) without compression and with vendor peak-
picking using MSConvert Chambers et al. (2012) (https://github.com/ProteoWizard). The
full list of fragment ion types (a-B, a, b, c, d, w, x, y, z) was considered for peak matching.
Precursor and fragment mass tolerance were both set to 3 parts per million. For precursor
mass correction, the monoisotopic up to the fifth (+4 neutrons) isotopologue peak were
considered.
The synthetic let-7 data was searched with NASE using unspecific cleavage to account for
incomplete RNA synthesis products. An extensive set of potential adducts (Na+, K+,
Na22+, K22+, NaK2+, Na33+, K33+, Na2K3+, NaK23+) was used because of the sub-
stantial salt that remained from the RNA synthesis reactions. Two copies of the let-7
sequence, one with a fixed 2’O-methylation of uridine (Um) at the 5’ position, were spec-
ified in the FASTA sequence file. The small size of the sequence database prevented the
use of a target-decoy approach for FDR estimation. I thus used a stringent hyperscore
cutoff of 150 (corresponding to the 1% FDR in the tRNA sample, see below) to define a
high-confidence set of results.
The NME1 data analysis used RNase T1 digestion with one allowed missed cleavage. m5C
was set as a variable modification; up to two modifications per oligonucleotide were con-
sidered. Na+ was specified as a potential adduct. The sequence database contained the
NME1 (target) sequence as well as a shuﬄed decoy sequence. Using these parameters I
successfully identified NME1.
In my search of the tRNA data, 26 variable modifications (based on previous findings in yeast
and human tRNA available in the Modomics database at http://modomics.genesilico.pl/
) were specified, at a maximum of three modifications per oligonucleotide. See Table 1
for the full list of modifications. Na+ was specified as a potential adduct. The FASTA file
contained 420 human tRNA sequences collected from the tRNA sequence database tRNAdb
Jhling et al. (2009)(http://trna.bioinf.uni-leipzig.de) plus the same number of reversed decoy
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sequences. The digestion parameters were set to RNase T1 with up to two missed cleavages.
Search engine comparison The NME1 data was processed with two other publicly
available RNA identification engines, in addition to NASE: Ariadne Nakayama et al. (2009)
and RNAModMapper Yu et al. (2017). To this end, the raw files were converted to MGF
format using MSConvert. Cleavage and variable modification settings in the searches were
the same as for NASE and appropriate for the samples. For Ariadne, the online version
at http://ariadne.riken.jp was used in October 2018. The “Calc as partial modifications”
option was enabled. The precursor and fragment mass tolerances were left at their default
values (5 and 20 ppm). Alternatively, using the parameters from Taoka et al. (2016b)
publication (20 and 50 ppm) made no appreciable difference for Ariadne’s performance in
tests. For RNAModMapper, a program version from July 2018 was used with settings
recommended by the author, Ningxi Yu. All available ion types (a-B, w, c, y) were enabled;
precursor and fragment mass tolerance were set to 0.02 and 0.1 Da, respectively.
Label-free Quantification In order to perform label-free quantification on the NME1
dataset, target coordinates (chemical sum formulas, charge states, median retention times)
for oligonucleotides identified at 1% FDR were exported from NASE. Based on these co-
ordinates, feature detection in the LC-MS raw data (mzML files) was carried out with
the OpenMS tool FeatureFinderMetaboIdent. The results were exported to text for-
mat using OpenMS’ TextExporter, for subsequent processing and visualization in R 3.5.1
Team (2018). Results from both NME1 samples were merged and feature intensities for
oligonucleotides were summed up over multiple charge and adduct states, where available.
To ensure comparability, manual adjustments were made in a few cases where modified
oligonucleotides had been identified with different m5C localizations in the two samples.
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3.3. Results
3.3.1. NucleicAcidSearchEngine
I developed a sequence database search engine for the identification of (modified) RNA se-
quences based on tandem mass spectra. The software, termed NucleicAcidSearchEngine
(NASE), was implemented in C++ within the OpenMS framework. The OpenMS library
was extended with classes representing (modified) ribonucleotides (based on data from
the MODOMICS database Boccaletto et al. (2018)), RNA sequences, and riboendonu-
cleases. A new generalized data structure for spectrum identification results (supporting
peptides/proteins, nucleic acid sequences, and small molecules) and an algorithm for theo-
retical spectrum generation of RNAs were added as well. The new executable tool NASE
combines this and existing OpenMS functionality (e.g. for data input/output, filtering, and
FDR estimation - see below).
Data processing with NASE works as follows: Inputs are an RNA sequence database
(FASTA format) and a mass spectrometry data file (mzML format). RNA sequences are
digested in silico using enzyme-specific cleavage rules for the user-specified RNase. Tandem
mass spectra are pre-processed (intensity filtering, deisotoping) and mapped to oligonu-
cleotides based on precursor masses. Theoretical spectra of the oligonucleotides in the
relevant charge states are generated and compared to the experimental spectra; matches
are scored using a variant of the hyperscore algorithm (Feny and Beavis 2003). If the se-
quence database contains decoy entries, the resulting oligonucleotide-spectrum matches can
be statistically validated through the automatic calculation of q-values, a measure of the
FDR Kll et al. (2008). Supported output formats are an mzTab-like text file Griss et al.
(2014), suitable for further analysis, and an XML file, suitable for visualisation in OpenMS’
interactive viewer, TOPPView Sturm and Kohlbacher (2009).
In addition to the built-in FDR calculation, NASE provides other features that set it apart
from alternative tools that are currently available. Even with extensive preparation, nu-
51
Figure 24: Annotated screenshot from TOPPView showing data from the NME1 control
sample, corresponding to the NCL1-treated data shown in Figure 4a. Note the loss of
signal intensity and sequence identifications for the methylated oligonucleotides, compared
to Figure 4a. Due to a lower-quality MS2 spectrum, the m5C site in UAACCCAUGp has
here been localized to the second, not third cytidine.
cleotide samples frequently contain salt adducts (in the form of cations attached to the
phosphate backbone). NASE searches can take this into account, by allowing users to
specify chemical formulas of adducts to consider in the precursor mass comparisons.
Furthermore, NASE supports the correction of precursor masses for MS2 spectra that were
sampled from isotopologue peaks other than the monoisotopic one. Especially for longer
sequences, MS2 precursor ions are often picked from heavier isotopologues by the mass
spectrometer’s data-dependent acquisition software, because the monoisotopic peaks are of
comparatively lower intensity. Without correction, the MS2 precursor masses would not
closely match the theoretical (monoisotopic) masses of the correct oligonucleotides, leading
to no assignment or incorrect matches. This feature thus greatly increases NASE’s ability
to identify oligonucleotides with longer sequences.
Finally, through the OpenMS toolbox NASE provides basic support for label-free quan-
tification of identified oligonucleotides. The core step of the quantitative workflow, the
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Figure 25: Data analysis pipeline for the NME1 data, comprising target/decoy database
generation, database search (incl. FDR estimation and filtering), targeted feature detection
and data export. Screenshot from TOPPAS, the OpenMS workflow editor. The whole
pipeline ran in only 12 seconds (single-threaded) on my server.
detection of chromatographic features in the LC-MS data, is handled by the OpenMS tool
FeatureFinderMetaboIdent (FFMetId). FFMetId is a variant of the proteomics tool Fea-
tureFinderIdentification Weisser and Choudhary (2017) which provides targeted feature de-
tection for arbitrary chemical compounds. NASE can write an output file with all relevant
information about the oligonucleotides it identified, which is directly suitable as an input
file for FFMetId. This allows seamless label-free quantification of the oligonucleotides that
were identified in a sample. Through the inclusion of a graphical workflow editor, OpenMS
makes it very easy to create and run data analysis pipelines Junker et al. (2012); an example
pipeline from my analysis of the NME1 data is shown in Fig. 25.
3.3.2. Synthetic let-7 analysis
There was a strong dependence of sequence coverage on the Normalized Collision Energy
(NCE) value. Identical samples were run with NCE ranging from 5 to 55. The best
results were obtained for an NCE of 20 (Figure 30). Subsequent LC-MS/MS analyses,
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Figure 26: A tandem MS spectrum of let-7 denoting all of the assigned peaks. The primary
ion was deprotonated seven times to give a charge state of -7 (m/z 971.55). The ion coverage
plot in the upper right shows coverage for nine different types of fragment ion (based on
the naming scheme of Mcluckey et al. (1992)).
including of the NME1 and tRNA samples, were thus carried out with this NCE setting.
At the optimal NCE, both unmodified and modified RNA were detected, and the location
of the modification could be determined with high confidence. 851 spectra were identified
that passed my hyperscore cutoff, matching sequences of length 5-21 nt, including the full-
length let-7. The shorter sequences correspond to artifacts of incomplete solid-phase RNA
synthesis, which are easily detectable by nLC-MS. In the full 21-nt sequence I averaged over
two-fold MS2 ion coverage of the let-7 sequence, with one or more forward (a-B/a/b/c/d)
ion and one or more reverse (w/x/y/z) ion detected at each base (see figure 26). This
demonstrates the software’s ability to sequence even relatively long (longer than 20 nt)
RNAs.
3.3.3. NME1 analysis
I processed the NME1 data using the three search engines Ariadne, RNAModMapper, and
NASE. I compared the results of my target/decoy database searches in terms of: A, the
number of identified spectra at different FDR thresholds; B, the sequence length distribution
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Figure 27: Performance comparison of RNA identification engines (Ariadne, RNAModMap-
per, NucleicAcidSearchEngine) based on searches of the NME1 data. Left: The number of
successfully identified spectra plotted against the q-value, a measure of the false discovery
rate, which was calculated from a target/decoy database search using each of the three
tools. Right: The sequence length distribution of identified oligonucleotides for each tool
at a confidence level of 5% FDR.
of the identified oligonucleotides at 5% FDR (Figure 27). NASE identified significantly more
spectra at a given confidence level than the other tools. It also found longer oligonucleotides,
which would be more informative for identifying RNAs in complex samples. About 8% of
the oligonucleotide-spectrum matches generated by NASE at 1% FDR included sodium
adducts (and would have been missed without the adduct search capabilities). Note that
Ariadne’s performance in this comparison was hampered by the fact that a recommended
tool for data preprocessing, the commercial software SpiceCmd, was not available to us.
RNAModMapper had previously been evaluated based on searches against expected se-
quences only (i.e. no decoys), followed by manual validation of spectral assignments Lobue
et al. (2018).
To assess reproducibility and the performance of my software at detecting RNA modifica-
tions, I compared the NASE search results for the NME1 lncRNA with and without NCL1
incubation (Figure 28). I considered results at a high confidence level of 1% FDR; at this
level, 74% sequence coverage was achieved for both the control and the NCL1-treated sam-
ple. As Figure 28 shows, there is good agreement between the unmodified oligonucleotides
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that were identified in both samples. While a number of m5C-modified oligonucleotides
were identified in the control sample, all except two of these false positives were observed in
only a single oligonucleotide-spectrum match - in proteomic LC-MS experiments, such single
hits would be commonly filtered out Cox and Mann (2008). I suspect that trace amounts
of carry-over from earlier test runs of the NCL1 sample on the same chromatographic
column may have caused these identifications in the control sample. Nonetheless, two mod-
ified oligonucleotides, UCACAAAU[m5C]G (at position 21-30 in the NME1 sequence) and
UAACC[m5C]AAUG (positions 299-308), were identified only in the NCL1-treated sam-
ple, based on 5 and 4 spectra in multiple charge states (-2 to -4 and -3 to -4, respectively).
These oligonucleotides thus provide strong evidence for true m5C modification sites (see also
Figures 30 and 31). In a few cases, NASE was unable to uniquely assign the location of a
cytidine methylation within an oligonucleotide sequence, reporting two alternative hits with
identical scores and different m5C sites. This is a common limitation that affects all search
engines (including Ariadne and RNAModMapper), caused by the absence of discriminating
peaks in the corresponding mass spectrum.
3.3.4. tRNA analysis
Previous work on tRNA Pan (2018b) has shown that it is heavily modified. My analysis
confirms this. I ran NASE on the short RNA fraction of a cell extract sample that had
been digested with RNAse T1. I searched for 26 variable modifications with different
molecular masses, which had previously been identified to be present in yeast or human
tRNA (Machnicka et al. (2015),Jhling et al. (2009)). Most of these represent sets of isobaric
modifications which I cannot distinguish, such as position-specific variants of the same
modification; e.g. m1A was used to represent any singly-methylated adenosine (incl. Am,
m6A etc.). Note that it was not feasible to search this dataset with this high number
of variable modifications using other available database-matching tools (RNAModMapper,
Ariadne). The full results are available in PRIDE (the PRoteomics IDentifications database)
. At an FDR cutoff of 5%, 1341 spectra were matched to oligonucleotide sequences, giving
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Figure 28: Coverage plot showing the NME1 RNA sequence and highlighting oligonu-
cleotides identified using NASE in the control (top) and NCL1-treated sample (bottom),
respectively. The bars corresponding to oligonucleotides are colored according to their
number of identifications (spectral counts) at 1% FDR. Putative 5-methylcytidine (m5C)
modification sites are marked in green. Sites with an asterisk (*) were uniquely localized,
while blank sites indicate uncertainty between two possible locations.
rise to 236 different oligonucleotides. The sequences of human tRNAs share significant
similarities, especially for tRNAs of one isotype, i.e. tRNAs that bind the same amino
acid. Consequently, only 38 (16%) of the identified oligonucleotides map to a unique tRNA
sequence; however, 225 (95%) map uniquely to a single tRNA isotype. Overall 385 of the
420 tRNA sequences in the search database had matching oligonucleotides. 35 tRNAs,
including ten variants of tRNA-Gly, were not detected at all. The sequence coverage, when
counting all matching oligonucleotides for each of the detected tRNA sequences, ranged
from 8.1% up to 54.8% (see Figure 29), with a median coverage of 20.8%. Many of the
oligonucleotides that were identified contained multiple modifications. In the search, up
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to three modifications per oligonucleotide were allowed, to limit the combinatorial space of
modified sequences that needed to be explored. Of the unique oligonucleotides identified at
5% FDR, 11% were unmodified (accounting for 16% of the identified spectra), while 36%
carried one, 26% carried two, and 25% carried three modifications (accounting for 45%, 23%
and 16% of the identified spectra, respectively) the preponderance of modifications were
on the tRNA loops, which is in agreement with previous experiments. All modifications
included in the search, except queuosine, wybutosine and their derivatives, were detected
as part of identified oligonucleotides. However, the prevalences of different modifications
differed widely - see Table 1 for details.
Existing data on the modification landscape of human cytosolic tRNAs is incomplete (e.g.
tRNAdb lists information for 20 genes covering 15 isotypes) and at least some modifications
are differentially regulated, complicating comparisons. I will focus on cytosine monomethy-
lation (mC, represented by m5C in my search) as one example that has been studied more
thoroughly, e.g. via bisulfite sequencing to detect m5C Gilbert et al. (2016). At 5% FDR
I identified 24 unique oligonucleotides with unambiguous assignments of mC. The oligonu-
cleotides contained one or two mC sites each and were supported by a total of 173 identified
spectra. Each mC-containing oligonucleotide was associated with one unique or predom-
inant (more matching genes) tRNA isotype. At the level of these isotypes, a total of 18
unique mC sites were identified. Seven of these sites agree with the canonical m5C sites
in the VL junction at consensus sequence positions 48-50 Blanco et al. (2014). Cytosine
methylation at position 34 in the anticodon, previously reported as m5C for tRNA-Leu-
CAA Brzezicha et al. (2006) and 2’-O-methylcytidine (Cm) for tRNA-Met in tRNAdb, was
here observed for tRNA-Met and tRNA-Trp. Methylation at C32 was found in a several tR-
NAs (tRNA-GlnCTG, tRNA-LeuTAA, tRNA-PheGAA, tRNA-Trp, tRNA-ValCAC); cor-
respondingly, Cm is reported at this position for tRNA-Gln and tRNA-Phe in tRNAdb. I
find that my results generally recapitulate annotated modifications in tRNAdb, in regions
where I have sequence coverage and with the caveat that I cannot distinguish between iso-
baric modifications (including uridine/pseudouridine). Known recurring modifications that
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Search mod. Represented isobaric Spectrum Unique oligo-
(short code) modification(s) matches nucleotides
m1A Adenosine monomethylation 391 55
m5U Uridine or pseudouridine monomethylation 247 46
t6A N6-threonylcarbamoyladenosine 222 29
m5C Cytidine monomethylation 173 24
m2G Guanosine monomethylation 114 26
D Dihydrouridine 107 26
I Inosine 78 26
acp3U 3-(3-amino-3-carboxypropyl)uridine 63 18
or -pseudouridine
i6A N6-isopentenyladenosine 55 13
m2,2G Guanosine dimethylation 48 13
ncm5s2U 5-carbamoylmethyl-2-thiouridine 43 17
ac4C N4-acetylcytidine or 37 14
5-formyl-2’-O-methylcytidine (f5Cm)
Ar(p) 2’-O-ribosyladenosine (phosphate) 26 14
mnm5U 5-methylaminomethyluridine 23 5
m1I Inosine monomethylation 20 7
m1Im Inosine dimethylation 10 6
f5C 5-formylcytidine 9 7
io6A N6-(cis-hydroxyisopentenyl)adenosine 5 4
m5Cm Cytidine dimethylation 3 3
m5D Dihydrouridine monomethylation 2 2
m6Am Adenosine dimethylation 2 1
m5Um Uridine or pseudouridine dimethylation 1 1
yW Wybutosine 0 0
Q Queuosine 0 0
o2yW Peroxywybutosine 0 0
galQ Galactosyl- or mannosyl-queuosine (manQ) 0 0
Table 1: Summary of modifications detected in the HAP1 tRNA data using NASE at a 5%
FDR level. Columns: 1. Short code of the modification specified as a search parameter.
2. The set of modifications implied by the corresponding mass shift, since e.g. position-
specific variants of a modification (Am, m1A, m6A etc.) generally cannot be distinguished.
3. Number of identified oligonucleotide-spectrum matches with at least one instance of the
corresponding modification in the sequence. 4. Number of unique oligonucleotides with at
least one corresponding modification among the search results.
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I detect in several tRNAs include monomethylation at G10, mono- or dimethylation at G26,
and monomethylation at A57. In many cases I find additional, alternatively modified (or
unmodified) variants of expected oligonucleotides.
3.3.5. Data visualization
TOPPView is the interactive viewer of the OpenMS suite Sturm and Kohlbacher (2009) and
allows multidimensional visualisation of tandem MS data. I extended TOPPView with capa-
bilities for visualizing RNA identification results obtained using NucleicAcidSearchEngine.
These extensions mirror and augment existing TOPPView functionality for visualizing pep-
tide identifications in proteomics experiments. First, identified sequences can be displayed
in the context of MS1 signal intensities, positioned according to their MS2 precursors in
a two-dimensional RT-by-m/z LC-MS map. Figure 30 shows an example from the NME1
data, focusing on the two (isobaric) oligonucleotides highlighted in the discussion of that
dataset and showing unmodified, adducted, and modified variants of them in charge state
-3 in the NCL1-treated sample. A corresponding image showing the loss of signal for the
modified oligonucleotides in the control sample can be seen in Figure 30.
Second, oligonucleotide-spectrum matches can be visualized by showing MS2 spectra with
annotations for matching peaks in the corresponding theoretical spectrum, analogous to
the identification view for peptide-spectrum matches. I augmented this view by adding an
ion coverage diagram in the top-right corner of the main window, indicating which of the
possible fragment ions were matched. Figure 31 shows an example comparing spectrum
matches for the two aforementioned modified oligonucleotides from the NME1 dataset.
3.3.6. Label-free quantification
I quantified the identified oligonucleotides in the two NME1 samples, using a label-free,
feature detection-based approach. Figure 32 summarizes the results. Although all oligonu-
cleotides come from the same RNA, they were quantified with signal intensities spanning
several orders of magnitude. This is indicative of widely varying ionization efficiencies dur-
60
ac4C
m1A
Ar(p)
ac4C
U
U
U
C
C
G
U
A
GUGU
AGU
G
G
U
U
A
U C A C
G
U
U
C
G
C
C
U
A
A
C
A
C
G
C
G
A
A
A
G
G
U
C
C C U G G
A U
C
A
A
AA
CCAGG
C
G
G
A
A
A
C
A
G
m5U
m2G
D
D Gm
5’
3’
Figure 29: A schematic depiction of Homo sapiens Val-AAC-3-1 tRNA. Sequences which
I detected at 5% FDR are highlighted in yellow for unmodified, and orange for modified
residues. Total coverage is 54.8%. The tRNAdb entry for tRNA-Val agrees with my find-
ings, except for the methylation at U4 (based on four identified spectra) and the three
modifications in the anticodon loop and stem (bottom right, based on two identified spec-
tra).
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Figure 30: A histogram showing the number of spectra identified as portions of Let7 at
various normalized collision energies between 15 and 55. Normalized Collision Energy is
an arbitrary value with no associated units. It is therefore likely to vary between different
instruments. The rapid drop-off in the number of hits above NCE 20 shows that controlling
fragmentation is very important for properly identifying RNA
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Figure 31: Screenshot from TOPPView’s identification view. Two MS2 spectra from the
NCL1-treated NME1 data, identified by NASE as the sequences UAACC[m5C]AAUGp and
UCACAAAU[m5C]Gp (cf. Figure 4), are compared. Matching peaks between the acquired
and theoretical spectrum are annotated and highlighted in red and green. In the top-
right corner of each spectrum plot, an ion coverage diagram shows which of the theoretical
fragment ions of the sequence were matched in the MS2 spectrum (in any charge state).
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ing MS analysis, a common caveat that generally limits label-free quantification to relative
comparisons between similar samples. Of 37 and 40 oligonucleotides that were identified
at 1% FDR in the control and NCL1-treated sample, respectively, 34 could be quantified
in each sample (corresponding to 92% and 85% success rates). Most oligonucleotides were
quantified at similar levels in both NME1 samples, with putative m5C-modified oligonu-
cleotides generally found at lower intensities. The notable exception is the pair of mod-
ified oligonucleotides UCACAAAU[m5C]G/UAACC[m5C]AAUG already discussed above.
While the chromatographic peaks for the unmodified oligonucleotides UCACAAAUCG and
UAACCCAAUG were distinct enough to allow separate quantification of each, their modi-
fied variants could only be quantified together. The difference in signal intensities for these
modified oligonucleotides between the control and NCL1-treated sample is clearly visible in
Figure 30 and Fig. 30. This difference is exacerbated in the label-free analysis by the fact
that only one corresponding identification was made in the control sample, while multiple
charge states were identified, quantified and aggregated in the NCL1-treated sample. (The
other obvious outlier, with the sequence AUUUAAAAAUUUUAAAUUG, was eluted for a
long period at the end of the chromatographic gradient and thus could not be quantified
reliably.) More advanced capabilities for LC-MS-based quantification, including retention
time alignment, inference of identified analytes across samples, and labelling approaches,
are already available in OpenMS for proteomics experiments. With future improvements
to the support for nucleic acids in the framework, these features will become available for
RNA analyses as well.
3.4. Discussion
NASE is a new open-source database search engine for RNA, optimised for high-resolution
MS data. It supports arbitrary modifications, salt adducts, and FDR estimation through a
target/decoy search strategy. Moreover, integration with the OpenMS toolbox enables high-
quality data visualisation, e.g. for manual validation of spectral assignments, and label-free
quantification of RNA oligonucleotides. I have tested NASE against a range of sample types
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Figure 32: Label-free quantification results for oligonucleotides identified in the NME1
dataset, comparing signal intensities in the control and NCL1-treated sample. Intensities
were aggregated over multiple charge and adduct states, where applicable. m5C-modified
oligonucleotides are marked in red. Oligonucleotides that were quantified in only one of
the samples are shown directly on the x and y axis, respectively. The grey diagonal line
represents equal intensity in both samples.
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and complexities, spanning synthetic nucleic acids, in vitro-transcribed sequences, and cell
extracts. In all of these experiments I have been able to effectively identify RNA sequences
and their modifications.
NASE contains many unique functionalities that are not currently realized in other database
search tools for RNA. To my knowledge, no other tools account for precursor mass defect
resulting from instrumental selection of higher isotopologue peaks. This functionality is
a major contributor to the excellent performance of NASE in identifying longer oligonu-
cleotides compared to other database-matching tools. In addition, despite extensive desalt-
ing steps, cation adduction is always present to some extent in oligonucleotide mass spectra
- NASE provides powerful correction for cation adduction events, which lessens the impact
of sodium and potassium ions on sequence characterisation. In addition, OpenMS in general
and NASE specifically were designed to be fast. My search times for complex samples are
orders of magnitude faster than other tools. The searches on the NME1 and let-7 data take
seconds; the much more complicated 20-modifications search of the tRNA dataset took 14
hours in multithreaded mode (20 parallel threads) on my server. For comparison, an anal-
ogous search using RNAModMapper was not feasible, with an estimated running time of
one month. Equivalent searches with Ariadne did not return any modified oligonucleotides.
Not least, the open-source nature of OpenMS and NASE enables users to modify the soft-
ware to fit their specific needs, to extend the existing functionality, and to create new in-
teroperating programs. Already, many analysis tools have been implemented within the
OpenMS framework for mass spectrometry-based proteomics and metabolomics experi-
ments. The present work gives a foretaste of the power of leveraging these methods for
the analysis of nucleic acid data. Future developments will streamline the use of OpenMS
tools and algorithms, e.g. for quantification and comparisons across many samples, in the
field of RNA epigenetics. In general, the development of NASE is an important step towards
the large-scale analysis of RNA by mass spectrometry.
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CHAPTER 4 : Putting it all together
4.1. Current directions
My technology is currently being put to good use in a couple of projects. Since these provide
a good blueprint for where these techniques and software can go I will give a basic overview
of the two ongoing projects which I am associated with.
Storm Therapeutics uses NASE to screen small-molecule RNA modifying en-
zyme inhibitors I developed NASE in concert with Hendrik Weisser from Storm Thera-
peutics. They needed a way to analyze the effectiveness of small-molecule inhibitors to RNA
modifying enzymes. Existing technologies for assessing RNA modifications were limited to
specific modifications, and many of them lacked the ability to determine what base of the
RNA was being modified. Mass spectrometry serves their needs well, and NASE is part of
their ongoing research.
The Garcia lab is looking for previously unidentified modifications to tRNA
The tRNA data that we collected as part of testing NASE has been the subject of ongoing
research into new, and previously unidentified tRNA modifications. By analysis of the data
for mass shifts corresponding ot theorized but unconfirmed modification sites we are able
to locate both new modifications and sites that were known to be modified, but for which
the type of modification was unknown. This work is ongoing and we hope to be able to
publish our results in the near future.
I am currently in discussion with Thermo Fisher Scientific to integrate NASE
Thermo Fisher has expressed interest in building NASE into their commercial offerings.
4.2. Future directions
The work that I detail in this dissertation is a solid start for the field of high throughput
RNA-modomics by mass spectrometry. From here there are a number of immediate ap-
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plications for the system, as well as a number of improvements that I plan on making, to
extend the abilities of the system.
Stable isotope labeling of nucleic acids Extending NASE to recognize pairs of heavy
and light nucleic acids offers a potential new field of study. Pairs of samples, one labeled
with a heavy isotope of a metabolic precursor, one not, is a well established experiment in
metabolomics. So-called SILAC (stable isotope labeling of amino acids in cell culture) has
been a valuable tool for proteomics and metabolomics in plumbing the depths of various
metabolic pathways. Indeed we have a much deeper understanding of which metabolic path-
ways lead to which peptide modifications through SILAC mass spectrometry. An analogous
method of study is potentially hugely valuable for determining the metabolic pathways tied
to specific nucleic acid modifications.
Knock-out studies Another potential future direction for investigation is pursuing stud-
ies knocking out various RNA modifying enzymes, and then using my techniques and soft-
ware to determine what modifications were caused by the enzymes. Through this method
researchers would be able to determine whether specific enzymes have different location
preferences for modifying RNA, and what modifications, if any are catalyzed by multi-
ple different modifying enzymes. This technique could be further abstracted to working
with knocking out other enzymes or proteins which are suspected to be involved in the
metabolism of modification precursors. Knockouts could even be combined with stable iso-
tope labeling for further targeting of our understanding of where modifications come from
biochemically, and what proteins are involved in their formation.
Measuring modification stoichometery In chapter 3 I talk briefly about NASE’s abil-
ity to generate label free quantification of modifications. This ability opens up a number
of potential research paths. Previously to these innovations I was only able to determine
whether a modification is present. Now I am able to determine both the presence of the
modification, and how the proportion modified versus unmodified sequences of total nucleic
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acid species changes between different samples. Equivalent studies in the field of histone
epigenetic markers have shown that being able to determine the fold change in modifica-
tion quantity gives key insight into what experimental conditions are associated with what
modification changes.
Parallelization improvements NASE performs very well and quickly on samples with
moderate complexity, unfortunately the addition of more potential modifications to be
searched causes an exponential growth in the amount of work the software needs to perform.
During the early analysis of the tRNA samples with more than 20 potential modifications
and up to three modifications on each sequence, runs could last up to two weeks running
single threaded. The current versions of NASE have multithreading support which decreases
the time to complete the above search in a matter of hours. Thus far I have not explored
the option to further spread out the processing of exceptionally large datasets to multiple
processors, or further to be able to run on cluster computers. As researchers use this software
for larger and more complicated datasets I predict that implementing multiprocessor and
cluster support in NASE will improve its overall usability and allow for even more cutting
edge experiments.
Moving away from ion-pair chromatography While I have managed to use ion-pair
chromatography to separate different nucleic acids it remains a less than optimal separation
mechanism, both because of instrument contamination as well as ion suppression. Exper-
iments by Garcia lab member Richard Lauman in using charged porous-graphitic-carbon
columns to separate nucleic acids have been encouraging and demonstrate a potential alter-
native to ion-pair chromatography. In brief, we have found that nucleic acids can be retained
on a porous-graphitic-carbon column without the aid of ion-pair reagents. This is the first
substrate that we are aware of which retains nucleic acids. We found that the nucleic acids
can then be eluted from the column through a combination of applying an electrical charge
to the column, and flushing with an organic solvent. Initial experiments have suffered from
breakdown of nucleic acids on the column into dimers and trimers, making this technique
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not quite ready for use in my applications, however we hope that by adjusting the voltage
across the column that we will be able to preserve longer nucleic acids. Given that using
porous-graphitic-caron columns with an attached power supply is a lot less expensive than
dedicating a high-performance liquid chromatograph and a dedicated mass spectrometer I
am hopeful that further study of this technique will increase the accessibility of nucleic acid
mass spectrometry to many more labs and researchers.
Better monoisotopic peak selection The mass spectrometers used in my experiments
can select ions of interest for fragmentation in a number of different ways. For all of the work
here I used a so-called data dependent acquisition (DDA), where the most intense ions for
which a charge state could be determined were collected for fragmentation and acquisiton of
tandem mass spectra. The instrument software provided along with our instruments allows
for a couple of alternative acquisition methods. The simplest of these is simply feeding a
list of masses to fragment when ions of that mass are detected. This selection method is
useful when searching against a small database of known nucleic acid sequences, but it does
not scale to samples for which the experimenter doesn’t know all of the sequences ahead
of time. For future work I propose adding DDA mode which takes both the charge state
of the precursor as well as the isotopic abundance of the peaks in the isotopic envelope.
Since nucleic acids have an elemental distribution which is known, and each element has an
isotopic distribution which is known, an approximate theoretical isotopic distribution for a
nucleic acid of a known mass can be calculated. I have already done this as part of the my
additions to FeatureFinderMultiplex. An improvement for the future would be to work
with the instrument manufacturers to include this feature as part of the selection criteria
for tandem mass spectra. I anticipate that such an improvement would greatly help with
selecting nucleic acids as opposed to other background in complicated samples.
4.3. Conclusions
Mass spectrometry is a viable and rich platform for the analysis of nucleic acid modifica-
tions. Separation and ionization efficiency issues plagued the early iterations of the system,
70
thankfully the use of the commercially available easySpray system coupled with having a
dedicated instrument for RNA have made the analytical method repeatable, stable, and
easy for other groups to replicate. The software platform has matured to the point at
which it is poised for integration into the standard OpenMS build. The experiments that
I have conducted have shown the software to be functional across a wide variety of nucleic
acid inputs, and able to handle the complexity of cellular samples. All of these parts taken
together speak to a bright future for nucleic acid mass spectrometry. By making these tools
available I hope that more labs will be able to partake in this interesting and growing field.
Likewise I think this project has great potential to continue to be expanded in the directions
I have mentioned above (among others) and I look forward to seeing what this nascent field
has in store for it.
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